Hydrosalpinx — assessment & management

My Dec 2025 HSG showed bilateral tubal occlusion — but proximal occlusion and frank hydrosalpinx are different problems with different consequences for IVF.
Last updated: Jun 10, 2026 1:47 PM CEST
TL;DR My HSG "no filling + venous extravasation" is the classic picture of proximal tubal occlusion (blocked at the uterine end), not frank hydrosalpinx (fluid-filled, dilated distal tube). HSG cannot see whether the distal tube is dilated — that's the embryo-toxic finding. I need a dedicated transvaginal ultrasound looking specifically for hydrosalpinx before my next transfer. If negative, no surgery; IVF bypasses proximal occlusion entirely. If positive, laparoscopic salpingectomy is the best-supported intervention and doesn't impair ovarian response.

Papers

Diagnostics · 2023
Delgado-Morell A et al. Transvaginal ultrasound accuracy in the hydrosalpinx diagnosis: a systematic review and meta-analysis
PMC

Finding: TVUS for hydrosalpinx has pooled sensitivity 84% and specificity 99% (positive likelihood ratio 80.7). Diagnostic finding: a dilated, fluid-filled, C- or S-shaped tubular structure >10 mm, distinct from the ovary.

Cochrane · 2022 (protocol)
Tros R et al. Visual tubal patency tests for tubal occlusion and hydrosalpinx
PMC

Finding: HSG and HyCoSy localize where a tube is blocked but cannot characterize what's beyond the block — meaning they can't distinguish frank hydrosalpinx from simple proximal occlusion. Laparoscopy with chromopertubation is the reference standard.

Ultrasound Obstet Gynecol · 2025
Pérez-Milán F et al. Hydrosalpinx treatment before in vitro fertilization: systematic review and network meta-analysis
PMC

Finding: For confirmed hydrosalpinx, salpingectomy ranks highest for ongoing pregnancy (OR 4.35, 95% CI 1.70–11.14) and does not impair ovarian response. Proximal tubal occlusion (clipping) is a close second (clinical pregnancy OR 2.55). Ultrasound-guided aspiration has a smaller, shorter-lived effect. No intervention is indicated for tubes that are NOT dilated.

Summary

The diagnostic gap

HSG and HyCoSy are good at saying "this tube is blocked" but not at saying "the blocked tube is full of toxic fluid." Only the latter harms IVF outcomes. The embryo-toxic mechanism is mechanical washout + cytotoxic fluid leaking back into the uterus — that requires a dilated distal tube. Proximal occlusion alone doesn't create that fluid.

Decision tree for my next cycle

  1. Request a dedicated TVUS for hydrosalpinx at the first CZ clinic visit. Operator should look for a dilated, fluid-filled, elongated structure >10 mm separate from the ovary, bilaterally.
  2. If TVUS is negative: no intervention. IVF bypasses proximal occlusion. Proceed to stim and transfer.
  3. If TVUS shows hydrosalpinx: discuss laparoscopic salpingectomy before the first transfer. Best evidence; doesn't harm AMH/AFC.
  4. If TVUS is equivocal: saline infusion sonography or MRI; diagnostic laparoscopy as the reference standard (and can treat in the same session).

Relation to my history

The HSG report itself flagged that I "may be amenable for bilateral fallopian tube recanalization." That's a procedure for proximal occlusion — which suggests the radiologist also read this as proximal block, not hydrosalpinx. The 2022 HyCoSy showed bilateral patency, so this is new pathology (likely subclinical infection or inflammation in the intervening years). Either way: the missing test is TVUS for hydrosalpinx, not recanalization.

Confidence: how well each finding applies to me

FindingConfidenceNote
My HSG is consistent with proximal occlusion, not hydrosalpinx High "No filling + venous extravasation" is textbook proximal block.
TVUS is the appropriate next test (sens 84%, spec 99%) High Standard non-invasive workup. Every clinic on my shortlist has in-clinic ultrasound.
If hydrosalpinx is confirmed, salpingectomy is the best-supported pre-IVF intervention High Effect size large; ovarian-reserve concern not supported by current data.
If TVUS is negative, no tubal surgery is needed High IVF bypasses tubes entirely. Proximal occlusion alone is not embryo-toxic.
The LBR-specific benefit of intervention is smaller than older trials suggested Medium 2025 NMA: ongoing pregnancy improves, LBR signal is not statistically significant in RCT-only pool.

Questions to raise with each CZ clinic

Caveats

↑ Back to top